$PBIO Pressure BioSciences and Leading Cosmeceutic
Post# of 1354
(Total Views: 168)
Posted On: 10/11/2022 9:38:43 AM
$PBIO Pressure BioSciences and Leading Cosmeceuticals Company Dr. Denese SkinScience Present Their Partnership Progress in FORCE Family Office October 13th Webinar
https://www.accesswire.com/719859/pressure-bi...th-webinar
Companies Will Discuss Actions and Planning Completed for a New Generation of Skincare Products, Offering Revolutionary Effectiveness Through Combination of PBI's UST Best-in-Class Nanoemulsification Technology with Dr. Denese's Unparalleled Science-Driven Understanding of the Needs in the Skincare Market
SOUTH EASTON, MA / ACCESSWIRE / October 11, 2022 / Pressure BioSciences, Inc. (OTCQB
BIO) ("PBI" and the "Company"
, a leader in the development and sale of innovative, broadly enabling, pressure-based instruments, consumables, and specialty testing services to the worldwide cosmeceuticals, health and wellness, and other industries today announced the Company's participation in the October 13th Development of a New Generation of Skincare Products webinar, sponsored by FORCE Family Office. PBI is honored to be joined by QVC icon, skincare visionary, and anti-aging pioneer Adrienne Denese, M.D., Ph.D. Dr. Denese is the President of Dr. Denese SkinScience, one of the most successful skincare lines in the U.S., with accumulated sales over $500 million through QVC.
PBI's revolutionary Ultra Shear Technology™ (UST™) platform, and its' critical enabling role in the development of a new generation of skincare products, will be the focus of this real-time, interactive "Presentation/Q&A Event". UST is a revolutionary and industrially-scalable technology that can process oil and water mixtures into nanoemulsions, in which large oil drops in water (containing active ingredients) are reduced to nano-sized oil droplets so small they achieve effective water-solubility and long-term stability. These high quality nanoemulsions show significantly increased absorption and bioavailability of the therapeutic active ingredients contained in the nano-sized oil droplets. Examples of active ingredients include retinol, vitamins, supplements, and nutraceuticals - all of which are routinely infused into cosmeceuticals.
Dr. Adrienne Denese's life mission has been to help women look and feel younger, and to live healthier lives. Her immutable priority has always been to effectively develop and deliver the highest quality active ingredients to her customers. Dr. Denese explained: "I am excited to partner with PBI as we together use the UST platform's remarkable breakthrough in nanoemulsion effectiveness to develop a new generation of category-changing skincare products that will offer more effective absorption, bioavailability, and therapeutic benefits to Dr. Denese SkinScience customers worldwide."
DATE: Thursday, October 13, 2022 (Noon ET)
PRESENTATION: Video Webcast
REGISTER: Click here to register for the Webinar
Panelists
Pressure BioSciences, Inc. (OTCQB BIO) announced on Wednesday, September 28th the imminent commercial launch of its revolutionary UST nanoemulsification processing method, with an initial focus in the CBD market. Company expects Q4 2022 incremental revenue to be in the hundreds of thousands of dollars and in the millions of dollars for FY 2023. Mr. Richard T. Schumacher, Founder and CEO, will be a panel participant.
Dr. Denese SkinScience is one of the most successful, highly-rated, award-winning, and longest-lasting skincare lines in the history of QVC. Dr. Adrienne Denese, Founder and President, will be a panel participant.
FORCE Family Office is the largest network of family offices in the United States. FORCE is dedicated to helping family offices efficiently and successfully connect with private and public companies for co-investment, research, education, and philanthropy. CEO Steven Saltzstein will be the Moderator of the webinar.
Selected Recent Key Announcements - PBIO
Pressure BioSciences Secures Pivotal Cosmeceuticals Partnership for UST Platform with Dr. Denese SkinScience, 20-Year Industry Leader with Over $0.5 Billion in QVC Sales.
Pressure BioSciences Announces First Nanoemulsions Manufacturing Agreement Under Recently Released UST Early Access Program
https://www.accesswire.com/719859/pressure-bi...th-webinar
Companies Will Discuss Actions and Planning Completed for a New Generation of Skincare Products, Offering Revolutionary Effectiveness Through Combination of PBI's UST Best-in-Class Nanoemulsification Technology with Dr. Denese's Unparalleled Science-Driven Understanding of the Needs in the Skincare Market
SOUTH EASTON, MA / ACCESSWIRE / October 11, 2022 / Pressure BioSciences, Inc. (OTCQB
BIO) ("PBI" and the "Company" , a leader in the development and sale of innovative, broadly enabling, pressure-based instruments, consumables, and specialty testing services to the worldwide cosmeceuticals, health and wellness, and other industries today announced the Company's participation in the October 13th Development of a New Generation of Skincare Products webinar, sponsored by FORCE Family Office. PBI is honored to be joined by QVC icon, skincare visionary, and anti-aging pioneer Adrienne Denese, M.D., Ph.D. Dr. Denese is the President of Dr. Denese SkinScience, one of the most successful skincare lines in the U.S., with accumulated sales over $500 million through QVC. PBI's revolutionary Ultra Shear Technology™ (UST™) platform, and its' critical enabling role in the development of a new generation of skincare products, will be the focus of this real-time, interactive "Presentation/Q&A Event". UST is a revolutionary and industrially-scalable technology that can process oil and water mixtures into nanoemulsions, in which large oil drops in water (containing active ingredients) are reduced to nano-sized oil droplets so small they achieve effective water-solubility and long-term stability. These high quality nanoemulsions show significantly increased absorption and bioavailability of the therapeutic active ingredients contained in the nano-sized oil droplets. Examples of active ingredients include retinol, vitamins, supplements, and nutraceuticals - all of which are routinely infused into cosmeceuticals.
Dr. Adrienne Denese's life mission has been to help women look and feel younger, and to live healthier lives. Her immutable priority has always been to effectively develop and deliver the highest quality active ingredients to her customers. Dr. Denese explained: "I am excited to partner with PBI as we together use the UST platform's remarkable breakthrough in nanoemulsion effectiveness to develop a new generation of category-changing skincare products that will offer more effective absorption, bioavailability, and therapeutic benefits to Dr. Denese SkinScience customers worldwide."
DATE: Thursday, October 13, 2022 (Noon ET)
PRESENTATION: Video Webcast
REGISTER: Click here to register for the Webinar
Panelists
Pressure BioSciences, Inc. (OTCQB
BIO) announced on Wednesday, September 28th the imminent commercial launch of its revolutionary UST nanoemulsification processing method, with an initial focus in the CBD market. Company expects Q4 2022 incremental revenue to be in the hundreds of thousands of dollars and in the millions of dollars for FY 2023. Mr. Richard T. Schumacher, Founder and CEO, will be a panel participant. Dr. Denese SkinScience is one of the most successful, highly-rated, award-winning, and longest-lasting skincare lines in the history of QVC. Dr. Adrienne Denese, Founder and President, will be a panel participant.
FORCE Family Office is the largest network of family offices in the United States. FORCE is dedicated to helping family offices efficiently and successfully connect with private and public companies for co-investment, research, education, and philanthropy. CEO Steven Saltzstein will be the Moderator of the webinar.
Selected Recent Key Announcements - PBIO
Pressure BioSciences Secures Pivotal Cosmeceuticals Partnership for UST Platform with Dr. Denese SkinScience, 20-Year Industry Leader with Over $0.5 Billion in QVC Sales.
Pressure BioSciences Announces First Nanoemulsions Manufacturing Agreement Under Recently Released UST Early Access Program
(0)
(0)Pressure Biosciences (PBIO) Stock Research Links
Scroll down for more posts ▼